Submitted Successfully!
To reward your contribution, here is a gift for you: A free trial for our video production service.
Thank you for your contribution! You can also upload a video entry or images related to this topic.
Version Summary Created by Modification Content Size Created at Operation
1
Helena Sá
 -- 5355 2022-10-19 15:55:01 |
2 I changed the references.
Helena Sá
 Meta information modification 5355 2022-10-19 16:03:46 | |
3 layout
Sirius Huang
 Meta information modification 5355 2022-10-20 06:45:05 |

Video Upload Options

Do you have a full video?
Send video materials Upload full video

Confirm

Are you sure to Delete?
Yes No
Cite
If you have any further questions, please contact Encyclopedia Editorial Office.
Sá, H.;  Michelin, M.;  Tavares, T.;  Silva, B. Biological Treatment of Pharmaceutical-Based Contaminants with Oxidoreductase Enzymes. Encyclopedia. Available online: https://encyclopedia.pub/entry/30233 (accessed on 19 April 2024).
Sá H,  Michelin M,  Tavares T,  Silva B. Biological Treatment of Pharmaceutical-Based Contaminants with Oxidoreductase Enzymes. Encyclopedia. Available at: https://encyclopedia.pub/entry/30233. Accessed April 19, 2024.
Sá, Helena, Michele Michelin, Teresa Tavares, Bruna Silva. "Biological Treatment of Pharmaceutical-Based Contaminants with Oxidoreductase Enzymes" Encyclopedia, https://encyclopedia.pub/entry/30233 (accessed April 19, 2024).
Sá, H.,  Michelin, M.,  Tavares, T., & Silva, B. (2022, October 19). Biological Treatment of Pharmaceutical-Based Contaminants with Oxidoreductase Enzymes. In Encyclopedia. https://encyclopedia.pub/entry/30233
Sá, Helena, et al. "Biological Treatment of Pharmaceutical-Based Contaminants with Oxidoreductase Enzymes." Encyclopedia. Web. 19 October, 2022.
Biological Treatment of Pharmaceutical-Based Contaminants with Oxidoreductase Enzymes
Edit
This entry is adapted from the peer-reviewed paper 10.3390/biom12101489

The worldwide access to pharmaceuticals and their continuous release into the environment have raised a serious global concern. Pharmaceuticals remain active even at low concentrations, therefore their occurrence in waterbodies may lead to successive deterioration of water quality with adverse impacts on the ecosystem and human health. To address this challenge, there is an evolving trend toward the search for effective methods to ensure efficient purification of both drinking water and wastewater. Biocatalytic transformation of pharmaceuticals using oxidoreductase enzymes, such as peroxidase and laccase, is a promising environmentally friendly solution for water treatment, where fungal species have been used as preferred producers due to their ligninolytic enzymatic systems.

oxidoreductases pharmaceuticals enzyme immobilization biodegradation wastewater

1. Occurrence and Toxicity of Pharmaceutical Active Compounds

Hundreds of tons of pharmaceutical compounds are annually dispensed and consumed worldwide [1]. Pharmaceutical active compounds (PhAC) are a group of hazardous contaminants and their fate in water bodies is an increasing environmental concern due to their high consumption, their persistence and activity, and their potential adverse effects on environmental health [2].
PhAC are chemical substances used to diagnose, prevent, treat and change diseases, infections, or discomforts [3]. A wide variety of human and animal medicines such as analgesics, non-steroidal anti-inflammatory drugs (NSAID), antibiotics, lipid regulators, beta-blockers, synthetic hormones and X-rays contrast media has become essential to ensure the health and well-being of the population and, therefore, to increase their life expectance [4].
The consumption of PhAC is set to increase in future years, due to population aging and improvements in health standards. Accordingly, several pharmaceuticals have been found in wastewater effluents, drinking water and in rivers at low concentrations ranging from ng/L to μg/L [5][6]. As can be seen in Figure 1, PhAC can be generated by different sources (e.g., agricultural activities, domestic and hospitals), as well as are designed to be biologically active and may affect non-target organisms. Although pharmaceuticals are usually designed with a single mechanism of action and target, non-target organisms may have receptors and, therefore, unexpected effects may result from unintended exposure [7].
Figure 1. Path of pharmaceuticals active compounds from the use to the disposal in the environment with some of the ecological side effects.
The prevalence of antibiotics in aquatic environments has become an important concern worldwide with the increasing occurrences of antibiotic-resistant bacteria and resistance genes in wastewater and even drinking water, due to their intensive use for veterinary, agricultural and human medical proposes [8][9]. Another major concern is their ability to interfere with the endocrine system to provoke undesired effects/disruption of homeostasis [5][10]. Continuous exposure to estrogens that are able to mimic and/or antagonize the effects of endogenous hormones produces adverse effects on the reproduction, development, and metabolism of aquatic organisms [11].
Most PhAC are currently not included in routine or regulatory control programs, which makes them candidates for future legislation. In this sense, the Commission Implementing Decision (EU) 2020/1161 has established a watch list of potential water pollutants for Union-wide monitoring in the field of water policy. Thus, azole pharmaceuticals, antibiotics and antidepressants such as clotrimazole, fluconazole, miconazole, amoxicillin, ciprofloxacin, sulfamethoxazole (SMX), trimethoprim and venlafaxine are some of the substances or groups of pharmaceuticals comprised [12].
The environmental concern related to the presence of PhAC in surface and groundwater is related to quantity, as well as their persistence and potential harm to human and aquatic life. The subsistence of trace pharmaceuticals and other contaminants in drinking water is a public health concern, since the potential chronic health effects associated with long term ingestion are scarcely known [13]. Although some compounds do not produce acute toxicity in the aquatic environment at low concentrations, constant release may lead to chronic and undesired synergistic effects with other compounds [14].

2. Enzymatic Biodegradation

Enzymes are catalysts that conduct, within the mild conditions of temperature and pH, chemical reactions at a remarkably high rate, efficiency and specificity [15]. Several enzyme systems have been used for the efficient transformation and degradation of organic pollutants and have been shown to oxidize and degrade the pollutants into smaller intermediates [16].
The literature survey shows that most enzymatic remediation studies use oxidoreductase enzymes [17][18]. These enzymes are largely produced by the white-rot fungi (WRF), as extracellular enzymes for the degradation of lignin. WRF and their ligninolytic enzymes, namely lignin peroxidase (LiP), manganese peroxidase (MnP), versatile peroxidase (VP) and Lac, have been demonstrated to be capable of transforming a wide range of compounds. This ability is a result of the structural similarities of several micropollutants to lignin, as well as the fact that ligninolytic enzymes are substrate-nonspecific [19]. Other enzymes are, as well, used as biocatalysts for the remediation of toxic compounds, such as tyrosinase, horseradish peroxidase (HRP) and phenoloxidase [17].
Peroxidases (EC 1.11.1.X) are a vast group of heme-containing oxidoreductases, which use hydrogen peroxide as an electron-acceptor to catalyze oxidative reactions [20], whereas Lac (EC 1.10.3.2) are glycosylated multi-copper oxidases that catalyzes one-electron oxidation of various substrates associated with the reduction of molecular oxygen to water, via a radical-catalyzed reaction mechanism [21]. In contrast to peroxidases that require the supply of hydrogen peroxide, Lac only requests oxygen as the final electron acceptor for the oxidation reaction to occur, offering an alternative green approach for the biodegradation of several PhAC [22]. Lac is selective towards phenolic compounds, but due to the non-specificity, they are also able to degrade aromatic amines and related substances, thiol groups, diamines, N-heterocycles and phenothiazines [23].
The active sites of Lac enzyme, as represented in Figure 2, contain four copper ions: one type 1 (T1) copper ion and a trinuclear copper cluster (TNC) composed of one type 2 (T2) copper ion coupled to binuclear type 3 (T3) copper ions [24]. The T1 copper site is the primary electron-acceptor for electrons offered by the substrate. The electrons are then moved to the TNC through highly conserved His-Cys-His tripeptide. After that, oxygen reacts with the fully reduced enzyme to form a peroxy-intermediate (PI), and then the PI is transformed back into a native intermediate, through a two-electron reduction. Once the fully reduced state is recovered, the final products are released from the TNC site. This results in the production of four radicals by the oxidation of four molecules of substrate, while one molecule of oxygen is reduced to two molecules of water and four protons (H+) are consumed from the solution [25][26].
Figure 2. Lac from Trametes versicolor (Protein Data Bank code 1KYA) (a). Representation of the different amino acids of the catalytic site that coordinates the T1, T2 and T3 copper sites (b), reprinted from Ref. [27].
The Lac and their active sites with copper ions play a key role in the reduction of oxygen. The redox potential (E°) difference between the T1 copper site and the substrate is one of the major factors that affect the oxidation rate. Accordingly, Lac are classified into three groups: low- (0.4–0.5 V), medium- (0.5–0.6 V) and high- (0.7–0.8 V) redox potential [28][29]. The variety of redox potentials is strictly related to the sources (e.g., bacterial, plant or fungi), due to the difference in the amino acid residues composition around the copper of the first reaction site. Lac from WRF has the highest redox potential, between 0.730 and 0.790 V, with phenylalanine as the non-coordinating axial ligand at the T1 copper site [30]. Among fungal species, Lac have been comprehensively identified from Ascomycetes and Basidiomycetes. Nonetheless, white-rot basidiomycetes such as Trametes versicolor, Pleurotus ostreatus or Cerrena unicolor, are noted for being efficient lignin degraders and Lac producers [17][31].
Several studies using enzyme extracts have been conducted for biodegradation of PhAC (Table 1). Although high efficiency rates are presented, the enzymatic wastewater treatment process is still relatively expensive, mainly due to the cost of commercial enzymes. One potential solution that may get the process cheaper is the application of crude enzymatic extracts. This might positively influence Lac catalytic activity and stability, as well as avoid the costly process of enzyme purification [20][32]. Furthermore, the crude extract offers efficient oxidation, since the synergistic action of the enzymes and a host of natural mediators and co-factors secreted by the fungi can potentially enhance the general performance [33].
Table 1. Examples of biodegradation of pharmaceutical micropollutants by enzymes.
Compound Enzyme Source PhAC (mg/L) Reaction Conditions Enzyme Load (U/L) Efficiency (%) Ref.
Diclofenac LiP Phanerochaete chrysosporium 5 pH 4, 24 mg/L H2O2, 25 °C, 2 h. 180 100 [34]
Lac Trametes versicolor 1 pH 6.5, 25 °C, 5 h. 500 >90 [35]
Lac Pycnoporus sanguineus 100 pH 5, 25 °C, 8 h. 100 50 [36]
5,7-Diiodo-8-hydroxyquinoline Lac Pycnoporus sanguineus 100 pH 5, 25 °C, 3.5 h. 100 78 [36]
Carbamazepine Lac Trametes versicolor 1 pH 6, 35 °C, 24 h. 60 30 [37]
Salicylic acid Lac Trametes pubescens 0.001 pH 6.9, 25 °C, 24 h. 100 >90 [38]
17-α-ethynyl estradiol Lac Trametes pubescens 0.001 pH 6.9, 25 °C, 24 h. 100 >90 [38]
Sulfamethoxazole Lac Phanerochaete chrysosporium 10 pH 4.5, 30 °C, 48 h. 6076 50 [39]
Lac Pycnoporus sanguineus 10 30 °C, 72 h. 170 29 [40]
17-β-estradiol Lac Trametes hirsuta 5 pH 5, 25 °C, 120 min. 5000 99 [31]
Lac Trametes pubescens 0.001 pH 6.9, 25 °C, 24 h. 100 >90 [38]
Tetracycline 1
Oxytetracycline 2		 MnP Phanerochaete chrysosporium 50 pH 4.8, 0.1 mM Mn2+, 0.1 mM H2O2, 37 °C, 4 h. 40 73 1
84 2		 [41]
Acetaminophen Lac Bjerkandera adusta TBB-03 20 pH 5–7, 25 °C, 2 h. 270 100 [42]
HRP Horseradish 6 pH 7.4, 400 μM H2O2, 25 °C, 4 h. 12800 100 [2]
Triclosan Lac Trametes versicolor 3 pH 6, 25 °C, 4 h. 2000 52 [43]
Doxorubicin Lac Trametes Versicolor 0.25 pH 7, 30 °C, 2 h. 900 100 [44]
Imipramine Lac Paraconiothyrium variabile 0.12 pH 5, 37 °C, 6 h. 1600 98 [45]
A huge amount of renewable biomass is generated annually due to agricultural, food and industrial activities. Agricultural and food wastes are often disposed of indiscriminately or burnt off, thereby constituting environmental hazards and contributing to global warming through the generation of greenhouse gases. To achieve environmental sustainability, value-addition to wastes and promotion of advances in the circular economy, agro-food wastes are now being investigated for valorization through bio-enzymatic approach [46]. For fungal cultures, a wide variety of lignocellulosic biomass has been used as an alternative substrate in submerged fermentation, solid-state fermentation or semisolid-state fermentation. Peanut shell, wheat straw, wheat bran, rice straw, rice bran, agave bagasse, sugarcane vinasse, corn bran, fruit peel, tea, sunflower seeds and apple pomace are some of the studied lignocellulosic wastes for Lac production for water remediation [47][48][49][50][51][52][53][54][55][56].
Lonappan et al. [35] present a novel insight on residue valorization and found that apple pomace and pulp and paper solid waste were capable of inducing Lac production by T. versicolor. The resulting crude enzyme was effective in the degradation of diclofenac sodium (DCF) at an environmentally relevant concentration (0.5 mg/L).
Kang et al. [42] stimulated the production of Bjerkandera adusta TBB-03 Lac using lignocellulosic substrates as the sole enzyme inducer (e.g., ash wood chips). The formed Lac consistently showed a high capability to degrade acetaminophen (APAP) under various conditions. The authors also defended a 22% of improvement in SMX removal in the presence of APAP, that could act as mediator for oxidation. Enzyme suspension with lower purification levels may contain phenolic compounds that act as natural mediators and consequently increase removal efficiency. For instance, Lac from a mushroom substrate, based on sawdust and wheat bran, colonized by P. ostreatus, demonstrates significant removal of DCF (90%), bicalutamide (43%) lamotrigine (73%) and metformin (49%), when compared with the control with an uncolonized mushroom substrate [57].
Most Lac used to degrade pharmaceuticals to date are mainly sourced from fungi. However, heterologous expression of Lac genes has attracted increasing attention due to the requirement to find more specific enzymes tailored to the complexity of wastewater matrices [58]. Protein engineering may provide higher enzyme yields and may allow the production of Lac with improved properties such as operational stability, pH stability, solvent stability and thermostability [59][60]. For example, a novel Lac derived from Bacillus tequilensis SN4 was demonstrated to be thermo-alkali-stable [60]. Lac Lcc9 from Coprinopsis cinerea expressed in Pichia pastoris also presented improved activity and stability at neutral and alkaline pH conditions [58]. Moreover, heterologous expressed bacterial Lac in Escherichia coli successfully degraded sulfanilamide antibiotics [61].

2.1. Laccase-Mediator Catalyzed System

Lac possess a relatively low redox potential (≤0.8 V) compared to peroxidase (>1 V). The redox potential difference between the substrate and the enzyme T1 copper affects the oxidative capacity of Lac. For example, Lac efficiently promotes single-electron oxidation of phenols. Accordingly, non-phenolic compounds, with redox potential above 1.3 V, are not directly prone to oxidation by Lac [62]. This lack of affinity of Lac is generally influenced by the distribution of functional groups in the chemical structure of the substrates. Compounds with electron withdrawing groups (EWG) such as carboxylic (-COOH), amide (-CONR2), halogen (-X) and nitro (-NO2) have lower enzyme affinity due to the less susceptible to oxidative catabolism [63].
The degradation efficiency of pollutants using Lac can be enhanced by the addition of redox mediators that are easily oxidized by the enzyme to free radicals. The presence of these small molecular weight compounds allows Lac to overcome a kinetic barrier and increase the spectrum of pollutants potentially degraded, as the mediator species have higher redox potentials. These compounds act as an “electron shuttle”, enabling the oxidation of complex substrates by highly reactive radicals that result from mediator oxidation by Lac. These radicals may return to their parent compound through reduction during the oxidation of the target pollutant [33][64].
Table 2 presents a list of redox mediators and their related information. The hydrogen atom transfer (HAT), electron transfer (ET) and ionic mechanisms are the primary mechanisms for mediator oxidation of a compound. The oxidation mechanism of the 2,2′-azino-bis (3-ethylbenzothiazoline-6-sulfonic acid) diammonium salt (ABTS) and 2, 2, 6, 6-tetramethyl-1-piperidinyloxy (TEMPO) radicals follows ET and ionic mechanisms, respectively. As well as p-coumaric acid, hydroxybenzotriazole (HBT), N-hydroxyphthalimide (HPI) and syringaldehyde (SA) follow HAT oxidation mechanism [65].
Table 2. Characteristics of redox mediators used in treatment of micropollutants by Lac-mediator systems.
Oxidation Mechanism Redox Mediator Origin Type of Mediator Free Radical Generated
Electron transfer 2,2′-azino-bis (3-ethylbenzothiazoline-6-sulfonic acid) diammonium salt Synthetic ABTS ABTS•+
ABTS2+
Hydrogen atom transfer Hydroxybenzotriazole Synthetic N–OH =N–O•
Aminoxyl
N-hydroxyphthalimide Synthetic N–OH =N–O•
Aminoxyl
Violuric acid Natural N–OH =N–O•
Aminoxyl
Vanillin Natural C6H4(OH)(OCH3) C6H5O•
Phenoxyl
Syringaldehyde Natural C6H4(OH)(OCH3) C6H5O•
Phenoxyl
Acetosyringone Natural C6H4(OH)(OCH3) C6H5O•
Phenoxyl
p-coumaric acid Natural C6H4(OH)(OCH3) C6H5O•
Phenoxyl
Ionic oxidation 2,2,6,6-tetramethylpiperidinyloxyl Synthetic N-O N=O•
Oxo-ammonium
The mediator type and concentration have a major impact on the practicality and feasibility of using Lac in PhAC degradation. Some literature studies that used mediators coupled with enzymes for pharmaceutical transformation are presented in Table 3. Naproxen (NPX) is an example of a recalcitrant drug able to resist enzymatic oxidation due to the presence of the EWG carboxyl and the absence of any strong electron-donating groups (EDG). Lac mediated with HBT achieved the greatest removal of NPX (80%) at the highest mediator concentration of 1 mM, while the performance of violuric acid (VLA), another N-OH type mediator, was weaker (~60%). At an inferior dose (0.5 mM), HBT and ABTS mediators still presented very efficient removal rates of NPX [66].
Table 3. Examples of biodegradation of pharmaceutical micropollutants by Lac coupled with reaction mediators.
Compound Lac Source Mediator Reaction Conditions Enzyme Load (U/L) Efficiency (%) Ref.
Diclofenac Trametes versicolor 1 mM of HBT 1 and SA 2 0.1 mg/L PhAC. 25 °C, 24 h. 1440 >95 1
80 2		 [33]
Carbamazepine Trametes versicolor 0.018 mM of ABTS 1 mg/L PhAC. pH 6, 35 °C, 24 h. 60 95 [37]
Sulfamethoxazole Trametes versicolor 0.5 mM ABTS, SA and AS 20-25 mg/L PhAC. pH 6–7, 25 °C, 2–6 h. 560 100 [64]
Tetracycline
Oxytetracycline		 Pycnoporus sp. SYBC-L10 1 mM of ABTS 50 mg/L PhAC. pH 6, 5 min, 0 °C. 10,000 100 [22]
Chloramphenicol Trametes hirsuta 0.5 mM of SA, vanillin, ABTS and α-naphthol 10 mg/L PhAC. pH 5, 25 °C, 48 h. 50,220 100 [32]
Ketoconazole Trametes versicolor 1 mM of HBT 300 mg/L PhAC. pH 4.5, 45 °C, 6 h. 1000 98 [67]
Naproxen Pleurotus ostreatus 1 mM of ABTS 0.5 mg/L PhAC. 25 °C, 8 h. 0.26 80 [66]
Olsalazine Aspergillus aculeatus 2 mM of ABTS 1, p-Coumaric acid 2 and HBT 3 100 mg/L PhAC. pH 5, 29 °C, 48 h. - 99 1
98 2
94 3		 [68]
Atenolol Trametes versicolor 0.5 mM of TEMPO 2.7 mg/L PhAC. pH 7, 25 °C, 4 h. 5000 80 [69]
Low molecular weight mediators allow complex compounds to access the active site of the enzyme. The oxidation of HBT by Lac generates small aminoxyl radicals that can remove the H atom from the O-H bond of phenolic substrates and consequently can create the phenoxyl radicals. The aforementioned mechanism may be responsible for the significant improvement in the degradation of salicylic acid [70].
In contrast to the low efficiency of the Lac degradation process without mediators, Lac coupled with ABTS revealed complete degradation of tetracycline (TC) and oxytetracycline (OTC) after only 4 min and 5 min, respectively [22]. Naghdi and co-authors [37] observed that 95% removal of carbamazepine (CBZ) was possible due to the combination of ABTS with crude Lac from T. versicolor. Furthermore, they reported that the enzyme concentration had a quadratic effect on biotransformation since an optimum level of Lac activity led to a rapid generation of ABTS radicals and caused an efficient transformation of CBZ, but further addition of enzyme to the solution increased the collisions and interactions and could block enzymes active sites. In the case of Lac-catalyzed degradation of the antibiotic chloramphenicol (CAP), Navada and co-authors [32] concluded that natural mediators (SA and vanillin) exhibited lower Km values than the reactions mediated by the synthetic mediators (ABTS and α-naphthol), showing that the natural mediators have a higher affinity to Lac than CAP and, therefore, increased the rate of oxidation reactions.
Ideally, during the oxidation of the pollutant, only oxygen is consumed in the catalytic cycle. However, the consumption of the mediator during the reaction is also possible. In this case, “Lac enhancer” is a more accurate term. Margot and co-authors [64] investigated and showed the potential of the Lac-mediator system for the degradation of the antibiotic SMX with ABTS, SA and acetosyringone (AS). From their results, neither ABTS, SA nor AS acted as catalysts, since these three mediators were consumed during the reaction, with a mediator/pollutant molar ratio between 1.1 and 16. The authors proposed an alternative model of oxidation in which Lac oxidize mediators to reactive radicals, that can transform into more stable products and react with each other or with pollutants.
Bankole and co-authors [68] demonstrated the effectiveness of ABTS, HBT and p-coumaric acid as redox mediators in the degradation of olsalazine by Lac from Aspergillus aculeatus. Furthermore, they observed that the increase in degradation efficiency was proportional to an increase in the concentration of mediators till a threshold value is reached, and at this point, no significant enhanced degradation of the pharmaceuticals occurs. This result is in line with the general trend observed in the literature that such threshold concentrations depend on the source of Lac, the target compound and the mediator used [33].
On the other hand, Lac catalyzed reaction with TEMPO, which produces the oxoammonium cation, was able to greatly promote atenolol (ATL) transformation in an aqueous solution, with complete removal after 12 h [69]. However, Wang et al. [69] also found that Lac would be deactivated more rapidly in the reactions with higher mediator concentration as a result of distortion or blockage of enzyme active sites by radicals. Other findings show that free radicals produced by the oxidation of a mediator can destabilize the enzyme by reacting with the aromatic amino residues on its outer surfaces [66].
Catalytic degradation using ligninolytic enzymes such as Lac with redox mediators may represent an alternative clean strategy for PhAC removal from the water matrix. However, the viability of this solution in real treatment systems is limited due to the necessity for high concentrations of mediator and the formation of several remediation products in concentrations eventually higher than the original pollutant [64].

2.2. Transformation Mechanisms and Toxicity Evaluation

Enzymes transform complex compounds into simpler substances and it is unknown whether pharmaceuticals are metabolized by remediating enzymes to less or more toxic products. There is also a lack of knowledge on the structure of the metabolites resulting from pharmaceuticals degradation process. Therefore, some authors have studied the transformation pathways, as well as metabolites toxicity or estrogenic activity.
Considering molecular weight and chemical structure, Kózka et al. [71] observed three main types of transformations of a series of antidepressants and immunosuppressants carried out by fungal ligninolytic enzymes. The first one is chemical oxidation and occurred for clomipramine, mianserin, sertraline, fluoxetine and citalopram. The second transformation is straight demethylation or demethylation coupled with other reactions such as oxidation or deamination, and was observed for clomipramine, mianserin, sertraline and venlafaxine transformation. The third type of transformation is the oxidative cleavage of the molecule into two parts of comparable size and was observed for fluoxetine and paroxetine.
Kasonga et al. [72] proposed the metabolic pathways for ibuprofen (IBP) and CBZ based on detected intermediates by a fungal consortium of Lac, LiP and MnP. The IBP transformation pathway appeared to result from hydroxylation with addition of hydroxyl group to 1,2-dihydroxy-IBP or carboxylation reaction leading to the substitution of the methyl group by carboxylic group to form IBP carboxylic acid. Furthermore, the CBZ metabolic pathway was presented in four routes. The first route proposed was oxidation or hydrolysis to iminostilbene. The second route consisted of oxidation reactions of the carbons on the aromatic benzene group to CBZ-2,3-quinone. The third route combined hydroxylation, hydrolysis and then oxidization to iminoquinone. The fourth and principal metabolic route started with oxidation or epoxidation and the end products were acridone, 10,11-dihydro-10-hydroxy-CBZ and 9-hydroxymethyl-10-carbamoyl acridan. Likewise, according to Naghdi et al. [37], 10,11-dihydro-10,11-dihydroxy-CBZ and 10,11-dihydro-10,11-epoxy-CBZ are considered to be the primary metabolites from CBZ oxidation by Lac-ABTS. Moreover, toxicity tests revealed that these products had no estrogenic effect.
In another study related to the degradation of DCF by Lac, the authors identified 3′-hydroxydiclofenac, 4′-hydroxydiclofenac, and 5-hydroxydiclofenac as the major transformation products [35].
Yang et al. [73] demonstrated that immobilized C. unicolor Lac was effective in detoxification of TC antibiotics and identified three transformation products with LC-TOF-MS. According to the authors, TC is first oxidized by Lac to the corresponding ketone and then the amino group is bi-demethylated to form the second transformation product. The final product results from oxidation, followed by water elimination and dehydrogenation.
Lac oxidation of SMX in presence of ABTS possibly results in two products from pharmaceutical degradation and a third one from ABTS oxidation by Lac, designated 3-ethyl-6-sulfonate benzothiazolinone imine [64]. In another study, Tian et al. [22] demonstrated that TC was first oxidized by Lac-ABTS to OTC as the major transformation product and proposed a degradation pathway including deamination, demethylation and dehydration.
The assessment of the overall toxicity of the treated effluents is essential to provide a more complete outlook of the environmental relevance of the enzymatic treatments in real practical applications. Several metabolites result from enzymatic water treatment and additional toxicological information by means of bioassays is imperative. These studies are able to describe the ecotoxicity and the estrogenic activity of the resulting metabolites.
Presently, there are examples of pharmaceutical enzymatic degradation that produce fewer toxic compounds and lack of estrogenicity effect. A micro-toxicity study with Pseudokirchneriella subcapitata, Candida albicans, Cryptococcus neoformans and Saccharomyces cerevisiae revealed that Lac-HBT treated ketoconazole and its isolated metabolites, such as 1-(4-{4-[2-(2,4-dichloro-phenyl)-2-imidazol-1-ylmethyl-[1,3]dioxolan-4-ylmethoxy]-phenyl}-4-oxy-piperazin-1-yl)-ethanone, suffered a decrease in the toxicity levels. The presence of the oxygen atom in the structure of metabolites reduces their lipophilicity and decreases their toxicity [67]. Furthermore, Lac-SA mediated system led to the transformation of CAP in chloramphenicol aldehyde and had less toxicity for microbial growth than mediators vanillin, ABTS and α-naphthol [32].
Spina et al. [74] showed that crude Lac from Trametes pubescens MUT 2400 was very active against all target micropollutants as ketoprofen, present in real municipal wastewater. Estrogenic analysis and toxicological tests with Raphidocelis subcapitata and Lepidium sativum showed a clear ecotoxicity reduction of treated wastewater. Similarly, Sun et al. [31] reported that a concentrated Lac isolated from Trametes hirsuta was capable of effectively metabolize 17b-estradiol (E2) more than 99% and potentially lead to a reduction of the estrogenic activity of E2. Through the combination of 13C-isotope labelling with high-resolution mass spectrometry, the dimers, trimers and tetramers were recognized as the primary by-products of E2 metabolism.
Contrarily, Becker et al. [75] verified that Lac mediated with SA effectively removes (>50%) a broad range of antibiotics after 24 h. However, this enhanced degradation induces unspecific toxicity. Furthermore, Feng et al. [69] verified that the transformation of ATL via Lac/TEMPO-catalyzed reaction greatly reduced the mortalities of zebrafish (Danio rerio) eggs, but the degradation products and the residual TEMPO still possess toxicity (approximately 40%). This transformation mainly involved hydroxylation, carbonylation, C–O bond cleavage and coupling reactions.

2.3. Immobilized Biocatalytic System

The practical application of freely suspended enzymes exhibits high activity in the biotransformation processes. Nevertheless, the free form is limited by the low stability and high cost of production for large scale implementation due to the impossibility of recovery [76][77]. To overcome such limitations, several studies have already demonstrated that enzyme activity and stability can be improved by immobilization on solid supports [17].
The stabilization of the peptide structure of the biocatalyst, creating interactions between the enzyme and an immobilization matrix, leads to enzyme stability and resistance improvement towards extreme operational conditions, including strong pH, high temperature or the presence of organic solvents [78]. Furthermore, immobilization allows the easy recovery of the enzyme and offers high reusability in several catalytic cycles without significant loss of its unique properties, which reduces operating costs [79].
The immobilization strategies are divided into methods based on physical or chemical interactions between enzymes and supports [80]. Physical immobilization involves the creation of non-specific interactions via hydrogen bonds, ionic and hydrophobic interactions. The physical methods include entrapment, encapsulation and adsorption, and there is no requirement for the functionalization of the support [17]. On the other hand, chemical immobilization includes enzyme attachment to the matrix by covalent binding or cross-linking [81]. An example of a covalent binding agent is glutaraldehyde that is capable to react with the amine groups at the surface of both enzymes and support through the formation of Schiff’s bases and Michael’s adducts [82]. Moreover, enzymes can be cross-linked to each other or create a cross-linked enzyme aggregate (CLEA) [83].
Physical adsorption is simpler and leads to higher final enzyme activity. However, desorption or leakage of the immobilized enzyme is common with cycles of use due to the relatively weak binding forces. Oppositely, chemical immobilization leads to partial deformations in the enzyme molecular shape but offers a robust attachment of enzymes to the support [78][84]. The characteristics of the support are essential to define the success of the final biocatalyst, therefore the ideal support for usage of industrial applications should be inert, rigid, inexpensive, eco-friendly and present thermal and mechanical resistances [85]. The support matrices can be classified according to their chemical composition as inorganic materials, organic materials, hybrids and composite materials. A large diversity of support has been developed due to the search for better stability and scale-up performance. Several recent methods of enzyme immobilization are summarized in Table 4.
Table 4. Examples of the removal of pharmaceutical compounds by immobilized enzyme.
Support Material Enzyme Immobilization Method PhAC Reaction Conditions Efficiency (%) Ref.
Poly(l-lactic acid)-co-poly(ε-caprolactone) nanofibers Lac from Trametes versicolor Encapsulation Naproxen 1 mg/L PhAC.
pH 5, 25 °C, 24 h, 100 rpm.		 90 [77]
Poly(l-lactic acid)-co-poly(ε-caprolactone) nanofibers Lac from Trametes versicolor Encapsulation Diclofenac 1 mg/L PhAC.
pH 3, 25 °C, 24 h, 100 rpm.		 90 [77]
Polyvinylidene fluoride membrane with multi-walled carbon nanotubes Lac from Trametes hirsuta Covalent bonding 5 mg/L PhAC.
pH 5, 25 °C, 4 h.		 95 [78]
Titania nanoparticles Lac from Pycnoporus sanguineus CS43 Covalent bonding 10 mg/L PhAC.
pH 4, 25 °C, 4 h.		 50 [86]
Micro-biochar from pine wood (PW) and pig manure (PM) Lac from Trametes versicolor Covalent bonding 0.5 mg/L PhAC.
pH 6.5, 25 °C, 5 h (PW) or 2 h (PM).		 99 [82]
Chitosan macro-beads Lac from Trametes versicolor Covalent bonding 50 mg/L PhAC.
pH 3, 25 °C, 4 h, 1:1 M ratio for ABTS:drug.		 90 [30]
CLEA Lac from Trametes versicolor Cross-linking 0.001 mg/L PhAC.
pH 5, 24 h, 22 °C.		 90 [83]
Polyacrylonitrile−biochar composite nanofibrous
membrane		 Lac from Trametes versicolor Covalent bonding 0.2 mg/L PhAC,
pH 4, 8 h, 35 °C.		 73 [87]
Polyacrylonitrile−biochar composite nanofibrous
membrane		 Lac from Trametes versicolor Covalent bonding Chlortetracycline 0.2 mg/L PhAC,
pH 4, 8 h, 35 °C.		 63 [87]
Polyvinylidene fluoride membrane with multi-walled carbon nanotubes Lac from Trametes hirsuta Covalent bonding Carbamazepine 5 mg/L PhAC.
pH 5, 25 °C, 48 h.		 27 [78]
Magnetite
nanoparticles		 HRP
LiP		 Adsorption 0.35 mg/L PhAC.
pH 3, 55 °C, 3 days.		 100 [88]
Polyimide aerogels Lac from Trametes versicolor Covalent bonding 0.02 mg/L PhAC.
pH 3, 25 °C, 24 h, 200 rpm.		 74 [89]
Pinewood nanobiochar Lac from Trametes versicolor Adsorption 0.02 mg/L PhAC.
pH 3.5, 25 °C, 24 h, 200 rpm.		 80 [76]
Polyamide/polyethylenimine nanofibers Lac from Trametes versicolor Covalent bonding Triclosan 10 mg/L PhAC.
pH 7, 25 °C, 20 h, 80 rpm.		 74 [90]
Titania nanoparticles Lac from Pycnoporus sanguineus CS43 Covalent bonding Acetaminophen 10 mg/L PhAC.
pH 4, 25 °C, 4 h.		 90 [86]
Commercial silica gel particles Lac from Trametes versicolor Covalent bonding Sulfamethoxazole 20 mg/L PhAC. pH 7, 25 °C, 0.5 h. 520 μM of ABTS. 53 [91]
Commercial silica gel particles Lac from Trametes versicolor Covalent bonding Amoxicillin 20 mg/L PhAC. pH 7, 25 °C, 4 h. 520 μM of ABTS. 80 [91]
M-CLEA Lac from Cerrena unicolor Cross-linking Tetracycline 100 mg/L PhAC.
pH 6, 25 °C, 48 h.		 100 [73]
Mesostructured cellular foam Lac from Trametes versicolor Adsorption 1 mg/L PhAC.
pH 5, 25 °C, 1 h.		 100 [92]
Bentonite-derived mesoporous materials Lac from Trametes versicolor Adsorption 10 mg/L PhAC. 30 °C, 3 h. 60 [84]
Cellulose
beads		 Lac from Trametes versicolor Covalent bonding Indole 15 mg/L PhAC.
pH 5, 30 °C, 18 h.		 100 [93]
Polypropylene beads Lac from Myceliophthora thermophila Adsorption Morphine 1 mg/L PhAC.
pH 6, 25 °C, 0.5 h.		 100 [94]
Graphene oxide and alginate matrix Lac from Aspergillus niger Adsorption/entrapment Cetirizine dihydrochloride 20 mg/L PhAC.
pH 4.5, 25 °C, 1 h.		 100 [95]
Pristine few layers graphene Lac from Trametes versicolor Adsorption Labetalol hydrochloride 1 mg/L PhAC pH 7, 25 °C, 1.5 h. 5 μM of ABTS. 100 [96]
A wide range of materials are used for enzyme immobilization. Zdarta and co-authors [77] studied Lac immobilization by adsorption and encapsulation using poly(l-lactic acid)-co-poly(ε-caprolactone) (PLCL) electrospun nanofibers. After 24 h, encapsulated Lac biodegraded over 90% of NPX and DFC, contrasting with an adsorbed enzyme which presented lower removal efficiency, 60% for NPX and 80% for DFC. This is mainly justified by the deactivation and elution of enzymes from the support. Dong and co-authors [96] described a mediating system in which Lac was assembled, over π-π interactions, onto pristine few-layer graphene (FLG) surface. The composite effectively transformed beta-blocker labetalol for more than 10 cycles, as the FLG increases the exposure extent of the catalytic center with the enhancement of the catalytic activity.
Immobilization of enzymes provides protection against denaturation and conformational changes. For example, Sharifi-Bonab and co-authors [95] immobilized Lac on graphene oxide (GO) nanosheets, followed by entrapment in alginate biopolymer. The immobilized Lac retained more than 70% of its initial activity after 10 days, contrarily to free Lac that became inactive. Furthermore, according to Zdarta and co-authors [92], Lac immobilized in mesostructured cellular foam (MCF) silica retained higher activity (80%) over a wider range of temperature and pH. The enzyme immobilized onto MCF + Cu preserved almost 90% of its initial activity after 10 cycles since the MCF has a protective effect towards Lac molecules immobilized onto the surface and into its pores. Similarly, Lac can enter into the narrow mesopores of meso-MIL-53(Al) by undergoing conformational changes and becoming immobilized in the mesopore-MIL-53(Al), thus the entrapment force is significantly higher compared to conventional physical adsorption [97]. In another example, Nguyen and co-authors [80] immobilized Lac on acid-washed granular activated carbon (GAC) via physical adsorption and observed that GAC-bound Lac maintained full activity for up to 8 cycles of continuous application.
Covalent binding of enzymes on solid materials for pollutant removal has been intensively investigated and yields efficient results. Masjoudi and co-authors [78] described a covalent immobilization of Lac on polyvinylidene fluoride (PVDF) membrane modified with multi-walled carbon nanotubes (MWCNT) and observed successfully removal of DCF (95% in 4 h) in a mini-membrane reactor. Likewise, Maryšková and co-authors [90] immobilized the Lac onto polyamide/polyethylenimine (PA/PEI) nanofibers, via covalent attachment, with the Lac retaining more than 52% of initial activity after 30 days and successfully degrading triclosan (~70%) and 17α-ethynylestradiol (~50%) in real wastewater effluent. In another work, Lac immobilization on titania nanoparticles (TiO2), with the functionalizing agent 3-aminopropyltriethoxysilane (APTES) and glutaraldehyde cross-linker, showed remarkable stability at 50 °C and 60 °C and low pH values of 2 and 3 [86].
Compared with literature data, Apriceno and co-authors [30] reported that a quite low value of enzymatic activity (0.02 U of enzyme) was required for 90% of degradation of DCF (50 mg/mL) in 3 h, when the Lac was covalently immobilized on chitosan beads and coupled with ABTS. Yaohua and co-authors [93] also reported an efficient degradation of índole, even after 5 and 10 cycles, using a co-immobilization method, which consisted on the encapsulation of ABTS molecules into the dual-functionalized cellulose beads, followed by covalent binding of Lac.
Magnetic cross-linked enzyme aggregates (M-CLEA) are another example of the enzyme immobilization method, in which amino-functionalized magnetic nanoparticles are used. Yang and co-authors reported that Lac immobilized as M-CLEA eliminated over 80 µg/mL of TC in 12 h [73]. Similarly, CLEA and M-CLEA Lac showed high DCF removal capacity (~80%) at 1 and 5 µg/L pollutant concentrations [83].
The use of immobilized biocatalysts for PhAC transformation leads to sustainable industrial process performance. Despite the promising results, there are still issues to be further investigated such as the production costs of the immobilized enzymes, the possibility of scaling biocatalytic systems, as well as storage stability and the treatment potential of numerous PhAC in real wastewater effluents using enzyme immobilized systems.

References

  1. Fekadu, S.; Alemayehu, E.; Dewil, R.; Van der Bruggen, B. Pharmaceuticals in Freshwater Aquatic Environments: A Comparison of the African and European Challenge. Sci. Total Environ. 2019, 654, 324–337.
  2. Stadlmair, L.F.; Letzel, T.; Drewes, J.E.; Graßmann, J. Mass Spectrometry Based in Vitro Assay Investigations on the Transformation of Pharmaceutical Compounds by Oxidative Enzymes. Chemosphere 2017, 174, 466–477.
  3. dos Santos, C.R.; Arcanjo, G.S.; de Souza Santos, L.V.; Koch, K.; Amaral, M.C.S. Aquatic Concentration and Risk Assessment of Pharmaceutically Active Compounds in the Environment. Environ. Pollut. 2021, 290, 118049.
  4. Couto, C.F.; Lange, L.C.; Amaral, M.C.S. Occurrence, Fate and Removal of Pharmaceutically Active Compounds (PhACs) in Water and Wastewater Treatment Plants—A Review. J. Water Process. Eng. 2019, 32, 100927.
  5. Dey, S.; Bano, F.; Malik, A. Pharmaceuticals and Personal Care Product (PPCP) Contamination-a Global Discharge Inventory. In Pharmaceuticals and Personal Care Products: Waste Management and Treatment Technology; Vara Prasad, M.N., Vithanage, M., Kapley, A., Eds.; Emerging Contaminants and Micro Pollutants: New Delhi, India, 2019; pp. 1–26. ISBN 9780128161890.
  6. Yang, Y.Y.; Zhao, J.L.; Liu, Y.S.; Liu, W.R.; Zhang, Q.Q.; Yao, L.; Hu, L.X.; Zhang, J.N.; Jiang, Y.X.; Ying, G.G. Pharmaceuticals and Personal Care Products (PPCPs) and Artificial Sweeteners (ASs) in Surface and Ground Waters and Their Application as Indication of Wastewater Contamination. Sci. Total Environ. 2018, 616–617, 816–823.
  7. Quesada, H.B.; Baptista, A.T.A.; Cusioli, L.F.; Seibert, D.; de Oliveira Bezerra, C.; Bergamasco, R. Surface Water Pollution by Pharmaceuticals and an Alternative of Removal by Low-Cost Adsorbents: A Review. Chemosphere 2019, 222, 766–780.
  8. Christou, A.; Agüera, A.; Bayona, J.M.; Cytryn, E.; Fotopoulos, V.; Lambropoulou, D.; Manaia, C.M.; Michael, C.; Revitt, M.; Schröder, P.; et al. The Potential Implications of Reclaimed Wastewater Reuse for Irrigation on the Agricultural Environment: The Knowns and Unknowns of the Fate of Antibiotics and Antibiotic Resistant Bacteria and Resistance Genes–A Review. Water Res. 2017, 123, 448–467.
  9. O’Flaherty, E.; Cummins, E. Antibiotic Resistance in Surface Water Ecosystems: Presence in the Aquatic Environment, Prevention Strategies, and Risk Assessment. Hum. Ecol. Risk Assess. 2017, 23, 299–322.
  10. Tijani, J.O.; Fatoba, O.O.; Babajide, O.O.; Petrik, L.F. Pharmaceuticals, Endocrine Disruptors, Personal Care Products, Nanomaterials and Perfluorinated Pollutants: A Review. Environ. Chem. Lett. 2016, 14, 27–49.
  11. Gore, A.C.; Chappell, V.A.; Fenton, S.E.; Flaws, J.A.; Nadal, A.; Prins, G.S.; Toppari, J.; Zoeller, R.T. Executive Summary to EDC-2: The Endocrine Society’s Second Scientific Statement on Endocrine-Disrupting Chemicals. Endocr. Rev. 2015, 36, 593–602.
  12. Commission Implementing Decision (EU) 2020/1161 of 4 August 2020 Establishing a Watch List of Substances for Union-Wide Monitoring in the Field of Water Policy Pursuant to Directive 2008/105/EC of the European Parliament and of the Council. Available online: http://data.europa.eu/eli/dec_impl/2020/1161/oj (accessed on 29 April 2021).
  13. Stackelberg, P.E.; Furlong, E.T.; Meyer, M.T.; Zaugg, S.D.; Henderson, A.K.; Reissman, D.B. Persistence of Pharmaceutical Compounds and Other Organic Wastewater Contaminants in a Conventional Drinking-Water-Treatment Plant. Sci. Total Environ. 2004, 329, 99–113.
  14. Rout, P.R.; Zhang, T.C.; Bhunia, P.; Surampalli, R.Y. Treatment Technologies for Emerging Contaminants in Wastewater Treatment Plants: A Review. Sci. Total Environ. 2021, 753, 141990.
  15. Bilal, M.; Rasheed, T.; Nabeel, F.; Iqbal, H.M.N.; Zhao, Y. Hazardous Contaminants in the Environment and Their Laccase-Assisted Degradation–A Review. J. Environ. Manag. 2019, 234, 253–264.
  16. Stadlmair, L.F.; Letzel, T.; Drewes, J.E.; Grassmann, J. Enzymes in Removal of Pharmaceuticals from Wastewater: A Critical Review of Challenges, Applications and Screening Methods for Their Selection. Chemosphere 2018, 205, 649–661.
  17. Zdarta, J.; Meyer, A.S.; Jesionowski, T.; Pinelo, M. Developments in Support Materials for Immobilization of Oxidoreductases: A Comprehensive Review. Adv. Colloid Interface Sci. 2018, 258, 1–20.
  18. Bilal, M.; Lam, S.S.; Iqbal, H.M.N. Biocatalytic Remediation of Pharmaceutically Active Micropollutants for Environmental Sustainability. Environ. Pollut. 2022, 293, 118582.
  19. Peralta, R.M.; da Silva, B.P.; Gomes Côrrea, R.C.; Kato, C.G.; Vicente Seixas, F.A.; Bracht, A. Enzymes from Basidiomycetes-Peculiar and Efficient Tools for Biotechnology. In Biotechnology of Microbial Enzymes; Brahmachari, G., Ed.; Academic Press: Cambridge, MA, USA, 2017; pp. 119–149. ISBN 9780128037461.
  20. Varga, B.; Somogyi, V.; Meiczinger, M.; Kováts, N.; Domokos, E. Enzymatic Treatment and Subsequent Toxicity of Organic Micropollutants Using Oxidoreductases-A Review. J. Clean. Prod. 2019, 221, 306–322.
  21. Morsi, R.; Bilal, M.; Iqbal, H.M.N.; Ashraf, S.S. Laccases and Peroxidases: The Smart, Greener and Futuristic Biocatalytic Tools to Mitigate Recalcitrant Emerging Pollutants. Sci. Total Environ. 2020, 714, 136572.
  22. Tian, Q.; Dou, X.; Huang, L.; Wang, L.; Meng, D.; Zhai, L.; Shen, Y.; You, C.; Guan, Z.; Liao, X. Characterization of a Robust Cold-Adapted and Thermostable Laccase from Pycnoporus sp. SYBC-L10 with a Strong Ability for the Degradation of Tetracycline and Oxytetracycline by Laccase-Mediated Oxidation. J. Hazard. Mater. 2020, 382, 121084.
  23. Monssef, R.; Hassan, E.; Ramadan, E. Production of Laccase Enzyme for Their Potential Application to Decolorize Fungal Pigments on Aging Paper and Parchment. Ann. Agric. Sci. 2016, 61, 145–154.
  24. Wang, K.; Huang, K.; Jiang, G. Enhanced Removal of Aqueous Acetaminophen by a Laccase-Catalyzed Oxidative Coupling Reaction under a Dual-PH Optimization Strategy. Sci. Total Environ. 2018, 616–617, 1270–1278.
  25. Jones, S.M.; Solomon, E.I. Electron Transfer and Reaction Mechanism of Laccases. Cell. Mol. Life Sci. 2015, 72, 869–883.
  26. Su, J.; Fu, J.; Wang, Q.; Silva, C.; Cavaco-Paulo, A. Laccase: A Green Catalyst for the Biosynthesis of Poly-Phenols. Crit. Rev. Biotechnol. 2018, 38, 294–307.
  27. Arregui, L.; Ayala, M.; Gómez-Gil, X.; Gutiérrez-Soto, G.; Hernández-Luna, C.E.; Herrera De Los Santos, M.; Levin, L.; Rojo-Domínguez, A.; Romero-Martínez, D.; Saparrat, M.C.N.; et al. Laccases: Structure, Function, and Potential Application in Water Bioremediation. Microb. Cell. Fact. 2019, 18, 200.
  28. Rodgers, C.J.; Blanford, C.F.; Giddens, S.R.; Skamnioti, P.; Armstrong, F.A.; Gurr, S.J. Designer Laccases: A Vogue for High-Potential Fungal Enzymes? Trends Biotechnol. 2010, 28, 63–72.
  29. Zimbardi, A.L.R.L.; Camargo, P.F.; Carli, S.; Neto, S.A.; Meleiro, L.P.; Rosa, J.C.; De Andrade, A.R.; Jorge, J.A.; Furriel, R.P.M. A High Redox Potential Laccase from Pycnoporus Sanguineus RP15: Potential Application for Dye Decolorization. Int. J. Mol. Sci. 2016, 17, 672.
  30. Apriceno, A.; Astolfi, M.L.; Girelli, A.M.; Scuto, F.R. A New Laccase-Mediator System Facing the Biodegradation Challenge: Insight into the NSAIDs Removal. Chemosphere 2019, 215, 535–542.
  31. Sun, K.; Cheng, X.; Yu, J.; Chen, L.; Wei, J.; Chen, W.; Wang, J.; Li, S.; Liu, Q.; Si, Y. Isolation of Trametes Hirsuta La-7 with High Laccase-Productivity and Its Application in Metabolism of 17β-Estradiol. Environ. Pollut. 2020, 263, 114381.
  32. Navada, K.K.; Kulal, A. Enzymatic Degradation of Chloramphenicol by Laccase from Trametes Hirsuta and Comparison among Mediators. Int. Biodeterior. Biodegrad. 2019, 138, 63–69.
  33. Nguyen, L.; Hai, F.; Kang, J.; Leusch, F.; Roddick, F.; Magram, S.; Price, W.; Nghiem, L. Enhancement of Trace Organic Contaminant Degradation by Crude Enzyme Extract from Trametes Versicolor Culture: Effect of Mediator Type and Concentration. J. Taiwan Inst. Chem. Eng. 2014, 45, 1855–1862.
  34. Zhang, Y.; Geißen, S.U. In Vitro Degradation of Carbamazepine and Diclofenac by Crude Lignin Peroxidase. J. Hazard. Mater. 2010, 176, 1089–1092.
  35. Lonappan, L.; Rouissi, T.; Laadila, M.A.; Brar, S.K.; Hernandez Galan, L.; Verma, M.; Surampalli, R.Y. Agro-Industrial-Produced Laccase for Degradation of Diclofenac and Identification of Transformation Products. ACS Sustain. Chem. Eng. 2017, 5, 5772–5781.
  36. Rodríguez-Delgado, M.; Orona-Navar, C.; García-Morales, R.; Hernandez-Luna, C.; Parra, R.; Mahlknecht, J.; Ornelas-Soto, N. Biotransformation Kinetics of Pharmaceutical and Industrial Micropollutants in Groundwaters by a Laccase Cocktail from Pycnoporus Sanguineus CS43 Fungi. Int. Biodeterior. Biodegrad. 2016, 108, 34–41.
  37. Naghdi, M.; Taheran, M.; Brar, S.K.; Kermanshahi-pour, A.; Verma, M.; Surampalli, R.Y. Biotransformation of Carbamazepine by Laccase-Mediator System: Kinetics, by-Products and Toxicity Assessment. Process. Biochem. 2018, 67, 147–154.
  38. Spina, F.; Cordero, C.; Schilirò, T.; Sgorbini, B.; Pignata, C.; Gilli, G.; Bicchi, C.; Varese, G.C. Removal of Micropollutants by Fungal Laccases in Model Solution and Municipal Wastewater: Evaluation of Estrogenic Activity and Ecotoxicity. J. Clean. Prod. 2015, 100, 185–194.
  39. Guo, X.L.; Zhu, Z.W.; Li, H.L. Biodegradation of Sulfamethoxazole by Phanerochaete Chrysosporium. J. Mol. Liq. 2014, 198, 169–172.
  40. Gao, N.; Liu, C.X.; Xu, Q.M.; Cheng, J.S.; Yuan, Y.J. Simultaneous Removal of Ciprofloxacin, Norfloxacin, Sulfamethoxazole by Co-Producing Oxidative Enzymes System of Phanerochaete Chrysosporium and Pycnoporus Sanguineus. Chemosphere 2018, 195, 146–155.
  41. Wen, X.; Jia, Y.; Li, J. Enzymatic Degradation of Tetracycline and Oxytetracycline by Crude Manganese Peroxidase Prepared from Phanerochaete Chrysosporium. J. Hazard. Mater. 2010, 177, 924–928.
  42. Kang, B.R.; Kim, S.Y.; Kang, M.; Lee, T.K. Removal of Pharmaceuticals and Personal Care Products Using Native Fungal Enzymes Extracted during the Ligninolytic Process. Environ. Res. 2021, 195, 110878.
  43. Sun, K.; Li, S.; Yu, J.; Gong, R.; Si, Y.; Liu, X.; Chu, G. Cu2+-Assisted Laccase from Trametes Versicolor Enhanced Self-Polyreaction of Triclosan. Chemosphere 2019, 225, 745–754.
  44. Kelbert, M.; Pereira, C.S.; Daronch, N.A.; Cesca, K.; Michels, C.; de Oliveira, D.; Soares, H.M. Laccase as an Efficacious Approach to Remove Anticancer Drugs: A Study of Doxorubicin Degradation, Kinetic Parameters, and Toxicity Assessment. J. Hazard. Mater. 2021, 409, 124520.
  45. Tahmasbi, H.; Khoshayand, M.R.; Bozorgi-Koushalshahi, M.; Heidary, M.; Ghazi-Khansari, M.; Faramarzi, M.A. Biocatalytic Conversion and Detoxification of Imipramine by the Laccase-Mediated System. Int. Biodeterior. Biodegrad. 2016, 108, 1–8.
  46. Elegbede, J.A.; Ajayi, V.A.; Lateef, A. Microbial Valorization of Corncob: Novel Route for Biotechnological Products for Sustainable Bioeconomy. Environ. Technol. Innov. 2021, 24, 102073.
  47. Pulicharla, R.; Das, R.K.; Kaur Brar, S.; Drogui, P.; Surampalli, R.Y. Degradation Kinetics of Chlortetracycline in Wastewater Using Ultrasonication Assisted Laccase. Chem. Eng. J. 2018, 347, 828–835.
  48. Patel, H.; Gupte, A. Optimization of Different Culture Conditions for Enhanced Laccase Production and Its Purification from Tricholoma Giganteum AGHP. Bioresour. Bioprocess. 2016, 3, 11.
  49. Lassouane, F.; Aït-Amar, H.; Amrani, S.; Rodriguez-Couto, S. A Promising Laccase Immobilization Approach for Bisphenol A Removal from Aqueous Solutions. Bioresour. Technol. 2019, 271, 360–367.
  50. Karp, S.G.; Faraco, V.; Amore, A.; Birolo, L.; Giangrande, C.; Soccol, V.T.; Pandey, A.; Soccol, C.R. Characterization of Laccase Isoforms Produced by Pleurotus Ostreatus in Solid State Fermentation of Sugarcane Bagasse. Bioresour. Technol. 2012, 114, 735–739.
  51. Xu, L.; Sun, K.; Wang, F.; Zhao, L.; Hu, J.; Ma, H.; Ding, Z. Laccase Production by Trametes Versicolor in Solid-State Fermentation Using Tea Residues as Substrate and Its Application in Dye Decolorization. J. Environ. Manag. 2020, 270, 110904.
  52. Omeje, K.O.; Nnolim, N.E.; Ezema, B.O.; Ozioko, J.N.; Eze, S.O.O. Synthetic Dyes Decolorization Potential of Agroindustrial Waste-Derived Thermo-Active Laccase from Aspergillus Species. Biocatal. Agric. Biotechnol. 2020, 29, 101800.
  53. Songulashvili, G.; Elisashvili, V.; Wasser, S.P.; Nevo, E.; Hadar, Y. Basidiomycetes Laccase and Manganese Peroxidase Activity in Submerged Fermentation of Food Industry Wastes. Enzyme Microb. Technol. 2007, 41, 57–61.
  54. Atilano-Camino, M.M.; Álvarez-Valencia, L.H.; García-González, A.; García-Reyes, R.B. Improving Laccase Production from Trametes Versicolor Using Lignocellulosic Residues as Cosubstrates and Evaluation of Enzymes for Blue Wastewater Biodegradation. J. Environ. Manag. 2020, 275, 111231.
  55. Li, G.; Liu, X.; Yuan, L. Improved Laccase Production by Funalia Trogii in Absorbent Fermentation with Nutrient Carrier. J. Biosci. Bioeng. 2017, 124, 381–385.
  56. Junior, J.A.; Vieira, Y.A.; Cruz, I.A.; da Silva Vilar, D.; Aguiar, M.M.; Torres, N.H.; Bharagava, R.N.; Lima, Á.S.; de Souza, R.L.; Romanholo Ferreira, L.F. Sequential Degradation of Raw Vinasse by a Laccase Enzyme Producing Fungus Pleurotus Sajor-Caju and Its ATPS Purification. Biotechnol. Rep. 2020, 25, e00411.
  57. Hultberg, M.; Ahrens, L.; Golovko, O. Use of Lignocellulosic Substrate Colonized by Oyster Mushroom (Pleurotus Ostreatus) for Removal of Organic Micropollutants from Water. J. Environ. Manage. 2020, 272, 111087.
  58. Xu, G.; Wang, J.; Yin, Q.; Fang, W.; Xiao, Y.; Fang, Z. Expression of a Thermo- and Alkali-Philic Fungal Laccase in Pichia Pastoris and Its Application. Protein Expr. Purif. 2019, 154, 16–24.
  59. Debaste, F.; Flahaut, S.; Penninckx, M.; Songulashvili, G. Chapter 15-Using Laccases for Food Preservation. In Handbook of Food Bioengineering; Grumezescu, A.M., Holban, A.M., Eds.; Academic Press: Cambridge, MA, USA, 2018; pp. 501–541.
  60. Sondhi, S.; Sharma, P.; George, N.; Chauhan, P.S.; Puri, N.; Gupta, N. An Extracellular Thermo-Alkali-Stable Laccase from Bacillus Tequilensis SN4, with a Potential to Biobleach Softwood Pulp. 3 Biotech 2015, 5, 175–185.
  61. Yang, L.H.; Qiao, B.; Xu, Q.M.; Liu, S.; Yuan, Y.; Cheng, J.S. Biodegradation of Sulfonamide Antibiotics through the Heterologous Expression of Laccases from Bacteria and Investigation of Their Potential Degradation Pathways. J. Hazard. Mater. 2021, 416, 125815.
  62. Cañas, A.I.; Camarero, S. Laccases and Their Natural Mediators: Biotechnological Tools for Sustainable Eco-Friendly Processes. Biotechnol. Adv. 2010, 28, 694–705.
  63. Yang, S.; Hai, F.I.; Nghiem, L.D.; Price, W.E.; Roddick, F.; Moreira, M.T.; Magram, S.F. Understanding the Factors Controlling the Removal of Trace Organic Contaminants by White-Rot Fungi and Their Lignin Modifying Enzymes: A Critical Review. Bioresour. Technol. 2013, 141, 97–108.
  64. Margot, J.; Copin, P.J.; von Gunten, U.; Barry, D.A.; Holliger, C. Sulfamethoxazole and Isoproturon Degradation and Detoxification by a Laccase-Mediator System: Influence of Treatment Conditions and Mechanistic Aspects. Biochem. Eng. J. 2015, 103, 47–59.
  65. Naghdi, M.; Taheran, M.; Brar, S.K.; Kermanshahi-pour, A.; Verma, M.; Surampalli, R.Y. Removal of Pharmaceutical Compounds in Water and Wastewater Using Fungal Oxidoreductase Enzymes. Environ. Pollut. 2018, 234, 190–213.
  66. Ashe, B.; Nguyen, L.N.; Hai, F.I.; Lee, D.J.; van de Merwe, J.P.; Leusch, F.D.L.; Price, W.E.; Nghiem, L.D. Impacts of Redox-Mediator Type on Trace Organic Contaminants Degradation by Laccase: Degradation Efficiency, Laccase Stability and Effluent Toxicity. Int. Biodeterior. Biodegrad. 2016, 113, 169–176.
  67. Yousefi-Ahmadipour, A.; Bozorgi-Koshalshahi, M.; Mogharabi, M.; Amini, M.; Ghazi-Khansari, M.; Faramarzi, M.A. Laccase-Catalyzed Treatment of Ketoconazole, Identification of Biotransformed Metabolites, Determination of Kinetic Parameters, and Evaluation of Micro-Toxicity. J. Mol. Catal. B Enzym 2016, 133, 77–84.
  68. Bankole, P.O.; Semple, K.T.; Jeon, B.H.; Govindwar, S.P. Impact of Redox-Mediators in the Degradation of Olsalazine by Marine-Derived Fungus, Aspergillus Aculeatus Strain Bpo2: Response Surface Methodology, Laccase Stability and Kinetics. Ecotoxicol. Environ. Saf. 2021, 208, 111742.
  69. Feng, Y.; Shen, M.; Wang, Z.; Liu, G. Transformation of Atenolol by a Laccase-Mediator System: Efficiencies, Effect of Water Constituents, and Transformation Pathways. Ecotoxicol. Environ. Saf. 2019, 183, 109555.
  70. Nguyen, L.; Hai, F.; Yang, S.; Kang, J.; Leusch, F.; Roddick, F.; Price, W.; Nghiem, L. Removal of Pharmaceuticals, Steroid Hormones, Phytoestrogens, UV-Filters, Industrial Chemicals and Pesticides by Trametes Versicolor: Role of Biosorption and Biodegradation. Int. Biodeterior. Biodegrad. 2014, 88, 169–175.
  71. Kózka, B.; Nałęcz-Jawecki, G.; Turło, J.; Giebułtowicz, J. Application of Pleurotus Ostreatus to Efficient Removal of Selected Antidepressants and Immunosuppressant. J. Environ. Manag. 2020, 273, 111131.
  72. Kasonga, T.K.; Coetzee, M.A.A.; Kamika, I.; Momba, M.N.B. Assessing a Co-Culture Fungal Granule Ability to Remove Pharmaceuticals in a Sequencing Batch Reactor. Environ. Technol. 2020, 43, 1684–1699.
  73. Yang, J.; Lin, Y.; Yang, X.; Ng, T.B.; Ye, X.; Lin, J. Degradation of Tetracycline by Immobilized Laccase and the Proposed Transformation Pathway. J. Hazard. Mater. 2017, 322, 525–531.
  74. Spina, F.; Gea, M.; Bicchi, C.; Cordero, C.; Schilirò, T.; Varese, G.C. Ecofriendly Laccases Treatment to Challenge Micropollutants Issue in Municipal Wastewaters. Environ. Pollut. 2020, 257, 113579.
  75. Becker, D.; Varela Della Giustina, S.; Rodriguez-Mozaz, S.; Schoevaart, R.; Barceló, D.; de Cazes, M.; Belleville, M.P.; Sanchez-Marcano, J.; de Gunzburg, J.; Couillerot, O.; et al. Removal of Antibiotics in Wastewater by Enzymatic Treatment with Fungal Laccase–Degradation of Compounds Does Not Always Eliminate Toxicity. Bioresour. Technol. 2016, 219, 500–509.
  76. Naghdi, M.; Taheran, M.; Brar, S.K.; Kermanshahi-pour, A.; Verma, M.; Surampalli, R.Y. Immobilized Laccase on Oxygen Functionalized Nanobiochars through Mineral Acids Treatment for Removal of Carbamazepine. Sci. Total Environ. 2017, 584–585, 393–401.
  77. Zdarta, J.; Jankowska, K.; Wyszowska, M.; Kijeńska-Gawrońska, E.; Zgoła-Grześkowiak, A.; Pinelo, M.; Meyer, A.S.; Moszyński, D.; Jesionowski, T. Robust Biodegradation of Naproxen and Diclofenac by Laccase Immobilized Using Electrospun Nanofibers with Enhanced Stability and Reusability. Mater. Sci. Eng. C 2019, 103, 109789.
  78. Masjoudi, M.; Golgoli, M.; Ghobadi Nejad, Z.; Sadeghzadeh, S.; Borghei, S.M. Pharmaceuticals Removal by Immobilized Laccase on Polyvinylidene Fluoride Nanocomposite with Multi-Walled Carbon Nanotubes. Chemosphere 2021, 263, 128043.
  79. Liu, D.M.; Chen, J.; Shi, Y.P. Advances on Methods and Easy Separated Support Materials for Enzymes Immobilization. TrAC-Trends Anal. Chem. 2018, 102, 332–342.
  80. Nguyen, L.N.; Hai, F.I.; Dosseto, A.; Richardson, C.; Price, W.E.; Nghiem, L.D. Continuous Adsorption and Biotransformation of Micropollutants by Granular Activated Carbon-Bound Laccase in a Packed-Bed Enzyme Reactor. Bioresour. Technol. 2016, 210, 108–116.
  81. Fernández-Fernández, M.; Sanromán, M.Á.; Moldes, D. Recent Developments and Applications of Immobilized Laccase. Biotechnol. Adv. 2013, 31, 1808–1825.
  82. Lonappan, L.; Liu, Y.; Rouissi, T.; Pourcel, F.; Brar, S.K.; Verma, M.; Surampalli, R.Y. Covalent Immobilization of Laccase on Citric Acid Functionalized Micro-Biochars Derived from Different Feedstock and Removal of Diclofenac. Chem. Eng. J. 2018, 351, 985–994.
  83. Primožič, M.; Kravanja, G.; Knez, Ž.; Crnjac, A.; Leitgeb, M. Immobilized Laccase in the Form of (Magnetic) Cross-Linked Enzyme Aggregates for Sustainable Diclofenac (Bio)Degradation. J. Clean. Prod. 2020, 275, 124121.
  84. Wen, X.; Zeng, Z.; Du, C.; Huang, D.; Zeng, G.; Xiao, R.; Lai, C.; Xu, P.; Zhang, C.; Wan, J.; et al. Immobilized Laccase on Bentonite-Derived Mesoporous Materials for Removal of Tetracycline. Chemosphere 2019, 222, 865–871.
  85. Daronch, N.A.; Kelbert, M.; Pereira, C.S.; de Araújo, P.H.H.; de Oliveira, D. Elucidating the Choice for a Precise Matrix for Laccase Immobilization: A Review. Chem. Eng. J. 2020, 397, 125506.
  86. García-Morales, R.; García-García, A.; Orona-Navar, C.; Osma, J.F.; Nigam, K.D.P.; Ornelas-Soto, N. Biotransformation of Emerging Pollutants in Groundwater by Laccase from P. Sanguineus CS43 Immobilized onto Titania Nanoparticles. J. Environ. Chem. Eng. 2018, 6, 710–717.
  87. Taheran, M.; Naghdi, M.; Brar, S.K.; Knystautas, E.J.; Verma, M.; Surampalli, R.Y. Covalent Immobilization of Laccase onto Nanofibrous Membrane for Degradation of Pharmaceutical Residues in Water. ACS Sustain. Chem. Eng. 2017, 5, 10430–10438.
  88. Pylypchuk, I.V.; Daniel, G.; Kessler, V.G.; Seisenbaeva, G.A. Removal of Diclofenac, Paracetamol, and Carbamazepine from Model Aqueous Solutions by Magnetic Sol–Gel Encapsulated Horseradish Peroxidase and Lignin Peroxidase Composites. Nanomaterials 2020, 10, 282.
  89. Simón-Herrero, C.; Naghdi, M.; Taheran, M.; Kaur Brar, S.; Romero, A.; Valverde, J.L.; Avalos Ramirez, A.; Sánchez-Silva, L. Immobilized Laccase on Polyimide Aerogels for Removal of Carbamazepine. J. Hazard. Mater. 2019, 376, 83–90.
  90. Maryšková, M.; Schaabová, M.; Tománková, H.; Vít, N.; Miroslava, R. Wastewater Treatment by Novel Polyamide/Polyethylenimine Nanofibers with Immobilized Laccase. Water 2020, 12, 588.
  91. Guardado, A.L.P.; Druon-Bocquet, S.; Belleville, M.P.; Sanchez-Marcano, J. A Novel Process for the Covalent Immobilization of Laccases on Silica Gel and Its Application for the Elimination of Pharmaceutical Micropollutants. Environ. Sci. Pollut. Res. 2021, 28, 25579–25593.
  92. Zdarta, J.; Feliczak-Guzik, A.; Siwińska-Ciesielczyk, K.; Nowak, I.; Jesionowski, T. Mesostructured Cellular Foam Silica Materials for Laccase Immobilization and Tetracycline Removal: A Comprehensive Study. Microporous Mesoporous Mater. 2020, 291, 109688.
  93. Yaohua, G.; Ping, X.; Feng, J.; Keren, S. Co-Immobilization of Laccase and ABTS onto Novel Dual-Functionalized Cellulose Beads for Highly Improved Biodegradation of Indole. J. Hazard. Mater. 2019, 365, 118–124.
  94. Huber, D.; Bleymaier, K.; Pellis, A.; Vielnascher, R.; Daxbacher, A.; Greimel, K.J.; Guebitz, G.M. Laccase Catalyzed Elimination of Morphine from Aqueous Systems. New Biotechnol. 2018, 42, 19–25.
  95. Sharifi-Bonab, M.; Arjomandi Rad, F.; Talat Mehrabad, J. Preparation of Laccase-Graphene Oxide Nanosheet/Alginate Composite: Application for the Removal of Cetirizine from Aqueous Solution. J. Environ. Chem. Eng. 2016, 4, 3013–3020.
  96. Dong, S.; Jing, X.; Cao, Y.; Xia, E.; Gao, S.; Mao, L. Non-Covalent Assembled Laccase-Graphene Composite: Property, Stability and Performance in Beta-Blocker Removal. Environ. Pollut. 2019, 252, 907–916.
  97. Jia, Y.; Chen, Y.; Luo, J.; Hu, Y. Immobilization of Laccase onto Meso-MIL-53(Al) via Physical Adsorption for the Catalytic Conversion of Triclosan. Ecotoxicol. Environ. Saf. 2019, 184, 109670.
More
© Text is available under the terms and conditions of the Creative Commons Attribution (CC BY) license; additional terms may apply. By using this site, you agree to the Terms and Conditions and Privacy Policy.
Upload a video for this entry
Information
Subjects: Engineering, Environmental
Contributors MDPI registered users' name will be linked to their SciProfiles pages. To register with us, please refer to https://encyclopedia.pub/register :
Helena Sá
,
Michele Michelin
,
Teresa Tavares
,
Bruna Silva
View Times: 518
Entry Collection: Wastewater Treatment
Revisions: 3 times (View History)
Update Date: 20 Oct 2022
Table of Contents
    1000/1000
    Hot Most Recent
    Feedback